drugset / Trial / NCT00392262

A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

NCT00392262

Phase 3 Completed 224 enrolled Novartis
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with amlodipine or felodipine alone.

Timeline

Start
2006-08
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Valsartan Small molecule 160 mg

Indications